Filing Details

Accession Number:
0001232524-18-000032
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-28 17:57:18
Reporting Period:
2018-02-26
Accepted Time:
2018-02-28 17:57:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1601583 P. Matthew Young 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Evp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2018-02-26 2,253 $147.44 36,706 No 4 F Direct
Ordinary Shares Disposition 2018-02-27 1,016 $144.96 35,690 No 4 S Direct
Ordinary Shares Disposition 2018-02-27 600 $145.83 35,090 No 4 S Direct
Ordinary Shares Disposition 2018-02-27 300 $147.30 34,790 No 4 S Direct
Ordinary Shares Disposition 2018-02-27 606 $143.80 34,184 No 4 F Direct
Ordinary Shares Disposition 2018-02-28 200 $145.25 33,984 No 4 S Direct
Ordinary Shares Disposition 2018-02-28 119 $147.56 33,865 No 4 S Direct
Ordinary Shares Disposition 2018-02-28 200 $149.02 33,665 No 4 S Direct
Ordinary Shares Disposition 2018-02-28 700 $150.00 32,965 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
  2. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  3. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.3100 to $145.2600. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  4. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.4300 to $146.2700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  5. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.0600 to $147.4400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  6. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.0500 to $145.4400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  7. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.2200 to $147.6200. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
  8. Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.6200 to $149.4100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.